Heart disease is a common and serious condition for people with diabetes, but with the information, tools and medications we have available today, heart disease is not only treatable but preventable.
[read_more text="read more" title="read more" url="https://tcoyd.org/2019/11/a-dose-of-dr-e-these-4-minutes-can-save-your-life-dont-die-of-heart-disease/" align="left"]
Jeremy Pettus explains the pros and cons of SGLT2s for people with type 1, and offers advice on how to try them safely and smartly.
[read_more text="read more" title="read more" url="https://tcoyd.org/2019/07/tips-for-type-1s-on-sglt2s/" align="left"]
The newest classes of diabetes meds to treat type 2 are pulling more than double duty, helping to better control blood sugars, protect the heart, lower body weight and prevent chronic kidney disease.
[read_more text="read more" title="read more" url="https://tcoyd.org/2019/03/diabetes-medicines-that-help-your-waistline-and-your-heart/" align="left"]
SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
[read_more text="read more" title="read more" url="https://tcoyd.org/2019/02/evaluating-type-2-meds-part-5-sglt-2-sodium-glucose-co-transporter-2-inhibitors/" align="left"]
We should all do what we can to keep our hearts healthy and happy. If you have type 2 diabetes, you are at an even higher risk of having heart disease. The good news is there is a lot you can do to prevent it!
[read_more text="read more" title="read more" url="https://tcoyd.org/2017/08/show-some-love-to-your-heart-tips-on-preventing-heart-disease/" align="left"]
